Metraipolis › archive › dc_134eccdfddfe

Efficacy, safety, and immunogenicity of proposed biosimilar RGB-19 and tocilizumab intravenously administered to adults with active rheumatoid arthritis and… — Europe PMC PMID:42370118

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42370118
DOI: 10.1016/j.ero.2025.12.010
License (as archived): solo-consultazione
Archived: 2026-11-06T12:02:35.881Z
SHA-256 of the archived text: 41046bd796028ac2f300151b9125569d24259f1c898fcd1512b447249102252b
Stable URL of this page: https://metraipolis.com/documento/dc_134eccdfddfe

How to cite

Efficacy, safety, and immunogenicity of proposed biosimilar RGB-19 and tocilizumab intravenously administered to adults with active rheumatoid arthritis and… — Europe PMC PMID:42370118 — Europe PMC (en), https://europepmc.org/article/MED/42370118 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_134eccdfddfe (Metraipolis archive dc_134eccdfddfe, sha256 41046bd796028ac2f300151b9125569d24259f1c898fcd1512b447249102252b)

BibTeX

@misc{dc134eccdfddfe,
  title = {Efficacy, safety, and immunogenicity of proposed biosimilar RGB-19 and tocilizumab intravenously administered to adults with active rheumatoid arthritis and… — Europe PMC PMID:42370118},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42370118},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_134eccdfddfe; sha256 41046bd796028ac2f300151b9125569d24259f1c898fcd1512b447249102252b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42370118. Agents can read the archived copy with the MCP tool read_document.